Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

OREX 4.50 +0.44 (10.84%)
price chart
Orexigen Launches Contrave - Watch For Traction
Orexigen (NASDAQ:OREX) announced today that the anti-obesity drug Contrave is now available for prescriptions in the United States.
Movers to Watch - Steven Madden, Ltd. (NASDAQ:SHOO), Orexigen ...  Techsonian (press release)
Takeda, Orexigen Therapeutics (OREX) Announces Availability of CONTRAVE  StreetInsider.com (subscription)
Related articles »  
Not Even a Weight Loss Drug Could Stop Orexigen Therapeutics, Inc. From ...
Those fears have sparked a flurry of research and development into drugs that could help reduce the risk of type 2 diabetes by helping patients lose weight, including Orexigen Therapeutics' (NASDAQ: OREX ) recently approved Contrave. Yet despite ...
Related articles »  
BUZZ-Orexigen Therapeutics Inc: Diet drug launched
Contrave, which was approved last month, competes with Vivus Inc's Qsymia and Arena Pharmaceutical Inc's Belviq.
Are People Too Concerned About Orexigen's Contrave Label? (OREX)
With its FDA Approval on September 11th 2014, Orexigen's (NASDAQ:OREX) Contrave became only the third anti-obesity drug to be approved by the FDA in over 10 years.
Stocks to Watch - Orexigen Therapeutics, Inc. (NASDAQ:OREX), Lennox ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) and its its wholly-owned subsidiary Takeda Pharmaceuticals have launched sales of Contrave extended-release tablets for chronic weight management in adults.
Related articles »  
Orexigen On A Tear - In The Wrong Direction
Based on the review of the data and the company's response to the CHMP lists of questions, at the time of the withdrawal the CHMP had some concerns and was of the provisional opinion that Belviq could not have been approved for weight control in obese ...
Top Stock Watch: iGATE Corporation (NASDAQ:IGTE), Orexigen Therapeutics ...
iGATE Corporation (NASDAQ:IGTE) reported Q3 financial results on Wednesday, with earnings in-line with the consensus of analysts polled by Capital IQ and revenues slightly beating the consensus.
Notable Runners �Orexigen Therapeutics, Inc. (NASDAQ:OREX), Amazon.com ...  Techsonian (press release)
Orexigen Up on $100M Milestone Payment from Takeda - Analyst Blog  NASDAQ
Related articles »  
Trending : Orexigen Therapeutics ,Achillion Pharma , Endo International ,Isis ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) : On September 23 and 24 , Meetings was held at New York and at Boston respectively hosted by Leerink.
Orexigen Therapeutics Stock Rating Reaffirmed by Zacks (OREX)
Orexigen Therapeutics, Inc. logo Orexigen Therapeutics (NASDAQ:OREX)'s stock had its �neutral� rating restated by Zacks in a research report issued on Friday.
Orexigen Therapeutics Sets New 1-Year Low at $3.11 (OREX)  Mideast Time
Stock's Buzzers - Solazyme, Inc. (NASDAQ:SZYM), AeropostaleInc (NYSE:ARO ...  Techsonian (press release)
Related articles »  
Investor's Alert - Orexigen Therapeutics, Inc. (OREX), Clean Energy Fuels Corp ...
Houston, TX - Oct 17, 2014 - (Techsonian) - Orexigen Therapeutics, Inc. (NASDAQ:OREX) released it has earned a $70 million milestone payment from partner Takeda Pharmaceuticals related to the shipment of Contrave� (naltrexone HCI and bupropion ...